Novel immunogens and methods for discovery and screening thereof

a technology of immunogens and immunogens, applied in the field of immunogen identification, can solve the problems of not fully optimizing the extraction or identification of the full antigen repertoire, and the cost of production and delivery, so as to reduce or protect against pneumococcal colonization

Inactive Publication Date: 2013-02-14
CHILDRENS MEDICAL CENT CORP
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0005]An aspect of the present invention provides for methods for identifying novel immunogens that when administered as vaccines elicit a cellular or humoral immunogenic respon

Problems solved by technology

Despite the effectiveness of the conjugate pneumococcal vaccines, problems with this approach remain including the expense of production and delivery, and resulting serotype replacement as demonstrated in seve

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel immunogens and methods for discovery and screening thereof
  • Novel immunogens and methods for discovery and screening thereof
  • Novel immunogens and methods for discovery and screening thereof

Examples

Experimental program
Comparison scheme
Effect test

example 1

Pneumococcal Immunogens

[0126]Protein Isolation

[0127]Initial efforts to isolate these proteins via gel filtration of the WCC supernatant did not yield discrete enough separation of proteins. Ultimately, preparative SDS gel transverse elution of the WCC supernatant improved separation of the proteins. WCC supernatant with SDS buffer was loaded into 10 wells of a precast 4%-12% Bis / Tris SDS gel with -100 μg protein / lane and run at 200V over 30 mM in MES-SDS buffer. This gel was equilibrated in 2 mM phosphate buffer for 20 mM in fresh buffer three times to minimize SDS. The equilibrated gel was cut to size to fit the BioRad Mini Gel Eluter apparatus. Proteins were transversely eluted through the thickness of the gel with 90 rnA of current for 20 mM. Eluates were collected into the elution chambers beneath the gel and harvested by vacuum apparatus. This method yielded fourteen eluates with one or two protein bands per eluate. The proteins within each eluate were visualized on silver stai...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Massaaaaaaaaaa
Fractionaaaaaaaaaa
Fractionaaaaaaaaaa
Login to view more

Abstract

The present application is generally directed to methods for identifying immunogens from organisms and pathogens, and in particular for identifying immunogens which when administered as vaccines elicit a cellular and/or humoral immune response. The present application is also directed to pneumococcal T-cell immunogens, and vaccine compositions comprising one or a combination of pneumococcal immunogens and methods for treating or preventing pneumococcal infections using the vaccines thereof. The present invention also encompasses use of the pneumococcal immunogens for diagnostic purposes to identify a subject with a pneumococcal infection.

Description

CROSS REFERENCE TO RELATED APPLICATIONS[0001]This application claims the benefit of priority under 35 U.S.C. §119(e) of U.S. Provisional Application No. 61 / 428,296 filed Dec. 30, 2010 and U.S. Provisional Application No. 61 / 428,305, also filed Dec. 30, 2010, and U.S. Provisional Application No. 61 / 313,450 filed Mar. 12, 2010 the contents of each of which are incorporated herein by reference in their entirety.FIELD OF THE INVENTION[0002]The present application is generally directed to methods for identifying immunogens from organisms and pathogens, and in particular for identifying immunogens which when administered as vaccines elicit a cellular and / or humoral immune response. The present application is also directed to pneumococcal T-cell immunogens, and methods and compositions thereof.BACKGROUND OF THE INVENTION[0003]Almost one million children in the developing world die of pneumococcal infections each year. Despite the effectiveness of the conjugate pneumococcal vaccines, proble...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K39/09A61P31/04G01N33/53A61K39/02C07K14/315
CPCA61K39/092C07K14/3156A61K2039/55544A61P11/00A61P31/00A61P31/04A61P31/10A61P31/12A61P33/00A61P37/02A61P37/04A61K2039/6087A61K2039/55583A61K2039/70C07K2319/00
Inventor MALLEY, RICHARDLU, YINGJIEMOFFITT, KRISTIN L.
Owner CHILDRENS MEDICAL CENT CORP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap